A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax
Open Access
- 1 January 2000
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 7 (1), 75-79
- https://doi.org/10.1038/sj.gt.3301048
Abstract
The bax gene plays a critical role in signaling apoptosis and expression through gene transfer may be valuable in the treatment of a variety of apoptosis-related diseases such as cancer. However, constructing an adenoviral vector expressing a bax gene driven by a constitutive promoter has been difficult, presumably because of the gene's high proapoptotic activity. Here we report a system that induces the expression of the bax gene safely by adenovirus-mediated gene cotransfer. Briefly, the system involves an adenoviral vector containing a human bax cDNA driven by a synthetic promoter consisting of five GAL4-binding sites and a TATA box (GT). This vector expresses a minimal background level of bax protein in cultured mammalian cells thus preventing apoptosis of packaging cells, however, expression of the bax gene can be induced substantially in vitro and in vivo by transferring it into target cells along with an adenoviral vector expressing the transactivator, fusion protein GAL4/VP16. Extensive apoptosis was observed after induction of the bax gene both in cultured human lung carcinoma cells and in the livers of Balb/c mice. Our results suggest that this GAL4 gene regulatory system provides an alternative approach to constructing viral vectors that express potentially toxic genes.Keywords
This publication has 13 references indexed in Scilit:
- Construction, Propagation, and Titer Estimation of Recombinant Adenoviruses Carrying Proapoptotic GenesHuman Gene Therapy, 1998
- Antitumor Activity of bax and p53 Naked Gene Transfer in Lung Cancer: In Vitro and In Vivo AnalysisHuman Gene Therapy, 1998
- Efficient Fas-ligand gene expression in rodent liver after intravenous injection of a recombinant adenovirus by the use of a Cre-mediated switching systemGene Therapy, 1998
- FasL induces Fas/Apo1-mediated apoptosis in human embryonic kidney 293 cells routinely used to generate E1-deleted adenoviral vectorsGene Therapy, 1998
- Adenoviral vectors for gene transferCurrent Opinion in Biotechnology, 1997
- Advances in adenoviral vectors: from genetic engineering to their biologyThe FASEB Journal, 1997
- Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymeraseCell, 1995
- Mapping of the human BAX gene to chromosome 19q13.3–q13.4 and isolation of a novel alternatively spliced transcript, BAXδGenomics, 1995
- Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.Proceedings of the National Academy of Sciences, 1994
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993